3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
41
Glioma
18
Brain Neoplasms
16
Astrocytoma
12
Neuroblastoma
10
Gliosarcoma
10
Neoplasms
8
Sarcoma, Ewing
7
Rhabdomyosarcoma
6
Oligodendroglioma
6
Recurrence
5
Sarcoma
4
Medulloblastoma
4
Diffuse Intrinsic Pontine Glioma
4
Neoplasm Metastasis
3
Melanoma
3
Wilms Tumor
2
Spinal Cord Neoplasms
2
Small Cell Lung Carcinoma
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Lymphoma, Follicular
2
Hepatoblastoma
2
Central Nervous System Neoplasms
2
Somatostatinoma
1
Rhabdoid Tumor
1
Refractory Solid Tumors
1
Pyloric Stenosis, Hypertrophic
1
Prostatic Neoplasms
1
Pheochromocytoma
1
Interventions
fludarabine
26
Cyclophosphamide
21
Azacitidine
20
venetoclax
18
Specimen Handling
18
fludarabine phosphate
17
Whole-Body Irradiation
14
Mycophenolic Acid
14
Melphalan
14
Busulfan
14
Biopsy
14
Tacrolimus
12
Cytarabine
12
Granulocyte Colony-Stimulating Factor
10
decitabine and cedazuridine drug combination
9
Decitabine
9
Stem Cell Transplantation
8
Sirolimus
8
Peripheral Blood Stem Cell Transplantation
8
Injections
8
Filgrastim
8
Cyclosporine
8
Thiotepa
6
ruxolitinib
5
X-Rays
5
Idarubicin
5
CPX-351
5
Magnetic Resonance Spectroscopy
4
Cladribine
4
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
Temozolomide
×
90 days
×
Clear all
No trials found.